Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Microbial Conversion. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108559766A reveals novel microbial route for steroid intermediates. Achieve higher purity and yield with scalable fermentation for reliable pharmaceutical supply chains.
High-yield microbial conversion method for D-chiro-inositol from myo-inositol. Scalable fermentation process offering cost reduction and supply reliability.
Patent CN102643879B reveals microbial route for duloxetine intermediate. High purity, scalable production offers significant supply chain and cost advantages.
Patent CN105779522B details high-yield enzymatic synthesis. Offers scalable production and purity for pharmaceutical supply chains.
Patent CN101824438B details microbial synthesis of high-purity (S)-EHB using yeast. Offers cost-effective, scalable pharmaceutical intermediate solutions.
Patent CN101824438A reveals microbial conversion for high-purity chiral intermediates. Offers cost reduction and scalable supply chain solutions for pharmaceutical manufacturing partners globally.